MHRA Guideline on Re-Manufacturing of Single-Use Medical Devices
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Last year the MHRA published a 11-page guidance about the re-manufacturing of single-use medical devices (SUDs). Although the guidance is only valid for the UK, its content is interesting.
Re-manufacturing of SUDs is allowed in the UK but the re-manufacturer should meet all relevant criteria under the current medical device directives prior to placing the device on the market. This should be verified regarding performance and safety by a notified body. That means that the intended use of the medical device is unchanged. A close loop contract should exist between re-manufacturers and health care institutions (e.g. hospital). Class I devices are exluded from re-manufacturing. The packaging or device must have the symbol for single-use only on it.
Very interesting is the 2,5 page glossary which explains among others the different terms reprocessing, fully refurbishing, re-use, single-use.
You can download the guidance on the MHRA website.
Related GMP News
27.05.2026Survey Results from Team Notified Body on the MDR and IVDR
27.05.2026FDA Q&A Document on the new GMP Regulations for Medical Devices
27.05.2026CDRH Annual Report 2025
13.01.2026MDCG publishes Guidance on the Surveillance of Medical Devices and IVDs
13.01.2026Real-world Evidence Data now also expanded in the Field of Medical Devices
06.11.2025FDA Warning Letter Statistics on Medical Devices in the Past Fiscal Year 2025


